Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
26
×
startups
26
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
deals
new york blog main
san diego blog main
san diego top stories
san francisco blog main
boston
new york top stories
investing
san francisco top stories
venture capital
cancer
clinical trials
financing
san diego
texas blog main
texas top stories
vc
boulder/denver blog main
fda
funding
glaxosmithkline
ipo
medical device
raleigh-durham blog main
raleigh-durham top stories
tc
biogen
boulder/denver top stories
detroit blog main
detroit top stories
health
indiana blog main
indiana top stories
What
new
26
×
drugs
medicines
biotech
medical
startup
drug
raised
developing
million
research
adds
bio
called
companies
company
life
therapeutics
advance
ceo
disease
diseases
innovation
investors
medicine
news
raises
roundup
san
science
stem
therapies
year
address
aims
approach
based
biopharmaceutical
capital
cells
Language
unset
Current search:
new
×
biotech
×
startups
×
@techcrunch.com
1 month ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@tech.eu
2 years ago
Why biotech investors are attracted to Lithuania
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@techcrunch.com
6 years ago
Biomedical startup AesculaTech is creating a new, more patient-friendly drug delivery system
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas